Roche

News

Roche seeks Kadcyla boost to fend off Herceptin biosimilars

As biosimilar competition to Herceptin ramps up, Roche is looking to bolster its position in HER2-positive breast cancer with a new indication for Kadcyla.

Views & Analysis

The future of patient value

Ahead of the 2019 eyeforpharma Barcelona conference, we asked speaker and awards judge Heather Moses – head of medical affairs at Roche – what she is looking for in winning patient init

News

Roche cancels two phase III Alzheimer’s trials

Roche and AC Immune have discontinued phase III trials of their Alzheimer’s disease drug crenezumab after an interim analysis indicated it would not hit its primary endpoint.

News

Genentech brings back Alexander Hardy to take CEO position

Roche has filled the open CEO position at Genentech with Alexander Hardy, a veteran of the subsidiary.

News

Ex-Roche, Novartis, AstraZeneca leaders appointed to biotech...

Three more big pharma R&D names have made the jump to biotech as Voyager Therapeutics, ImmunSYS and Immunocore announce they have appointed former execs from Roche, Novartis and AstraZe

News

Roche's SMA drug gets PRIME regulatory status in Europe

Roche is hoping to challenge Biogen with a new treatment for the rare muscle wasting disease spinal muscular atrophy – and the plans just got a boost after European regulators gave it speci

Roche seeks Kadcyla boost to fend off Herceptin biosimilars

The future of patient value

Roche cancels two phase III Alzheimer’s trials

Genentech brings back Alexander Hardy to take CEO position

Ex-Roche, Novartis, AstraZeneca leaders appointed to biotech...

Roche's SMA drug gets PRIME regulatory status in Europe

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Roche

Editor's Picks